Robert Hoffman

Robert Hoffman discloses dealings in Antibe Therapeutics Inc. to SEDI. In total, 6 filings cover trades dated from 24 November 2020 to 11 January 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 13 January 2024, the filings show an option exercise worth €8,500 in Antibe Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.